Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs, rapid…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
Search Posts
Blog
CEI Files Opening Brief in “Vapes on a Plane” Lawsuit
Today, CEI filed its opening brief against the U.S. Department of Transportation (DOT), Office of the Secretary of Transportation’s March final rule prohibiting electronic cigarette…
Blog
Q&A on the FDA’s New E-Cigarette Rules
After years of waiting and fighting, the new rules put forth by the U.S. Food and Drug Administration (FDA) on electronic cigarettes and other non-cigarette…
Blog
RealClear Radio Hour: War on Cancer
In this week’s episode of RealClear Radio Hour, we tackle the war on cancer. Disruptive innovators, Stephen Bonner and Paul Davies, confront bureaucracy and big…
Blog
Deflate Drug Prices by Reforming the FDA
This Wednesday, the Senate Select Committee on Aging will hold a hearing on “sudden price spikes” among certain off-patent drugs. The most widely publicized of these…
Blog
A Big Payoff for Patient Investors
There’s a fascinating story in The New York Times this week about pharmaceutical companies and the process of discovering new drugs. Fifteen years ago, the…
Study
Compound Fracture
Drug compounding involves reformulating or repackaging approved medicines to better tailor them to patients’ needs. Adding new federal regulations to further restrict compounding would do…